LUCENTIS (Genentech, Inc.)
Welcome to the PulseAid listing for the LUCENTIS drug offered from Genentech, Inc.. This Vascular Endothelial Growth Factor Inhibitors [MoA],Vascular Endothelial Growth Factor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | RANIBIZUMAB |
| SUBSTANCE NAME: | RANIBIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vascular Endothelial Growth Factor Inhibitors [MoA],Vascular Endothelial Growth Factor Inhibitor [EPC] |
| ROUTE: | INTRAVITREAL |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2006-06-30 |
| END MARKETING DATE: | 0000-00-00 |
LUCENTIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | LUCENTIS from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2006-06-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-080_3324ea2f-1ca4-403c-8049-61108762e7c7 |
| PRODUCT NDC: | 50242-080 |
| APPLICATION NUMBER: | BLA125156 |
Other RANIBIZUMAB Pharmaceutical Manufacturers / Labelers:
